Two news outlets reported that FDA officials are considering adding a boxed (black‑box) warning to COVID‑19 vaccines, citing internal deliberations at the agency and a leaked staff memo. Sources named senior FDA figures associated with the review and described a process under way to decide whether the highest‑level label should be appended to vaccine prescribing information. Public‑health and clinical experts quickly criticized the move in op‑eds and commentaries, saying current safety data do not support such a sweeping action and warning it could sharply reduce vaccine uptake. The agency has not finalized a decision; its spokespeople framed external reports as premature. Industry and clinicians will monitor any formal label change for impacts on public confidence, pediatric and pregnancy guidance, and vaccine program logistics. For readers: boxed warnings signal serious risks and are the FDA’s most visible safety flag.